The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of the combination of alisertib (MLN8237) and gemcitabine in advanced solid tumors.
 
Edward Jae-hoon Kim
Consulting or Advisory Role - Bayer; Momenta Pharmaceuticals
Research Funding - Celgene (Inst)
 
Thomas John Semrad
Consulting or Advisory Role - Amgen; Celgene; Genentech; Genomic Health; Onyx
Research Funding - Astex Pharmaceuticals (Inst); Eisai (Inst); Genentech (Inst); Millennium (Inst); Morphotek (Inst); Novartis (Inst)
 
David R. Gandara
Honoraria - Array BioPharma; AstraZeneca; Celgene; Lilly; Novartis; Synta
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech; GlaxoSmithKline; Lilly; Merck; Novartis; Pfizer; Response Genetics; Sanofi; Synta
Research Funding - Abbott Laboratories (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); ImClone Systems (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Biomarin; Boehringer Ingelheim; Dava Oncology; Pfizer
 
Jonathan Riess
Honoraria - Roche/Genentech
Research Funding - Millennium; Onconova Therapeutics
Travel, Accommodations, Expenses - Roche/Genentech
 
Tianhong Li
Speakers' Bureau - Pfizer
Research Funding - Astellas Pharma (Inst); Lilly (Inst); Novartis (Inst)
 
Aiming Yu
Patents, Royalties, Other Intellectual Property - International patent PCT/US2013/021307 (Inst); U.S. application serial no. 62/003,806 (Inst)
 
Karen Matsukuma
Employment - PathGroup
Honoraria - Elsevier
 
Philip C. Mack
Research Funding - Boehringer Ingelheim
 
Karen Kelly
Consulting or Advisory Role - Boehringer Ingelheim; Clovis Oncology; Daiichi Sankyo; Genentech; Lilly; Synta; Transgene
Research Funding - EMD Serono (Inst); Genentech (Inst); Lilly (Inst); Millennium (Inst); Novartis (Inst); Proacta (Inst)